Garth W Strohbehn (Garth Strohbehn)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Nature reviews. Clinical oncology

JCO oncology practice

Clinical trials (London, England)

Nature biotechnology

University of Chicago Medical Center

University of Iowa (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chicago Medical Center

United States

Fellow :: Section of Hematology/Oncology, Department of Medicine

Education History

University of Iowa

United States

BSC

Publications

Garth W Strohbehn, Bishal Gyawali
'Contribution of component' and the perioperative immune-checkpoint inhibitor precedent. Nature reviews. Clinical oncology (2024)
Garth W Strohbehn, Mark J Ratain
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders. Nature reviews. Clinical oncology (2024)
Garth W Strohbehn, Mark J Ratain
Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders. Nature reviews. Clinical oncology 21 (5) (2024)
Garth W Strohbehn, Bishal Gyawali
'Contribution of component' and the perioperative immune-checkpoint inhibitor precedent. Nature reviews. Clinical oncology 21 (4) (2024)
Garth W Strohbehn, Allen S Lichter, Mark J Ratain
US Government Payer-Funded Trials to Address Oncology's Drug-Dosing Conundrum: A Congressional Call to Action? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Philip S Boonstra, Alex Tabarrok, Garth W Strohbehn
Targeted randomization dose optimization trials enable fractional dosing of scarce drugs. PloS one 18 (10) (2023)
Garth W Strohbehn, Walter M Stadler, Philip S Boonstra, Mark J Ratain
Optimizing the doses of cancer drugs after usual dose finding. Clinical trials (London, England) (2023)
Sofia I Jacobson, Alec J Kacew, Randall W Knoebel, Po-Hung Hsieh, Mark J Ratain, Garth W Strohbehn
Alternative Trastuzumab Dosing Schedules Are Associated With Reductions in Health Care Greenhouse Gas Emissions. JCO oncology practice (2023)
Garth W Strohbehn, Walter M Stadler, Philip S Boonstra, Mark J Ratain
Optimizing the doses of cancer drugs after usual dose finding. Clinical trials (London, England) 21 (3) (2023)
Kamya Sankar, Alex K Bryant, Garth W Strohbehn, Lili Zhao, David Elliott, Drew Moghanaki, Michael J Kelley, Nithya Ramnath, Michael D Green
Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer. Cancers 14 (3) (2022)
Po-Hung Hsieh, Alec J Kacew, Marie Dreyer, Anthony V Serritella, Randall W Knoebel, Garth W Strohbehn, Mark J Ratain
Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. NPJ breast cancer 8 (1) (2022)
Garth W Strohbehn, Govind Persad, William F Parker, Srinivas Murthy
Dose optimisation and scarce resource allocation: two sides of the same coin. BMJ open 12 (10) (2022)
Garth W Strohbehn, Alec J Kacew, Daniel A Goldstein, Robin C Feldman, Mark J Ratain
Combination therapy patents: a new front in evergreening. Nature biotechnology (2021)
Alec J Kacew, Sofia Jacobson, Jori Sheade, Anand A Patel, Fay J Hlubocky, Nita K Lee, Tara O Henderson, John A Schneider, Garth W Strohbehn
Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers. Journal of adolescent and young adult oncology (2021)
Cindy Y Jiang, Garth W Strohbehn, Rachel M Dedinsky, Shelby M Raupp, Brittany M Pannecouk, Sarah E Yentz, Nithya Ramnath
Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts. JCO oncology practice 17 (9) (2021)
Garth W Strohbehn, Kathryn Levy, Phoebe A Tsao, Daniel T Cronin, Lauren A Heidemann, John Del Valle
The 'July Effect' in supervisory residents: assessing the emotions of rising internal medicine PGY2 residents and the impact of an orientation retreat. Medical education online 25 (1) (2020)
Garth W Strohbehn, Brian L Heiss, Sherin Juliet Rouhani, Jonathan A Trujillo, Jovian Yu, Alec J Kacew, Emily F Higgs, Jeffrey C Bloodworth, Alexandra Cabanov, Rachel C Wright, Adriana Koziol, Alexandra Weiss, Keith Danahey, Theodore G Karrison, Cuoghi C Edens, Iazsmin Bauer Ventura, Natasha N Pettit, Bhakti Patel, Jennifer Pisano, Mary E Strek, Thomas F Gajewski, Mark J Ratain, Pankti D Reid
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv : the preprint server for health sciences (2020)
Garth W Strohbehn, Gurpreet Dhaliwal, Henry Paulson, Joseph Murray, Sanjay Saint
Repetition. The New England journal of medicine 380 (18) (2019)
Garth W Strohbehn, Elliot B Tapper, John Del Valle
Transforming Chief Residents into Chief Scholars. Medical science educator 29 (4) (2019)
Garth W Strohbehn, Christopher K Daugherty
Mistaking the Trees for the Forest? The oncologist 25 (4) (2019)

Garth W Strohbehn.css-eqlu8i{font-size:small;padding-left:4px;} (Garth Strohbehn)

Publication Activity (10 Years)

Top Topics

Top Venues

Garth W Strohbehn (Garth Strohbehn)